-- 
Adobe, Analogic, Oracle, Orexigen, Vivus : U.S. Equity Preview

-- B y   I n y o u n g   H w a n g
-- 
2011-09-21T04:00:03Z

-- http://www.bloomberg.com/news/2011-09-20/adobe-systems-analogic-oracle-orexigen-vivus-u-s-equity-preview.html
Shares of the following companies
may have unusual moves in U.S. trading. Stock symbols are in
parentheses.  Adobe Systems Inc. (ADBE)  : The world’s largest maker of
graphic-design software forecast fourth-quarter revenue of at
least $1.08 billion, exceeding analysts’ estimates of $1.07
billion on average, citing demand from business customers.  Analogic Corp. (ALOG)  : The medical and airport-security
device maker reported fourth-quarter earnings of 83 cents a
share, beating the 62 cent average estimate of two analysts.  Oracle Corp. (ORCL)  : The Redwood City, California-based
supplier reported a first-quarter profit of 48 cents, topping
analysts’ estimates by 1 cent, as companies increased spending
on database software and applications that help run their
businesses.  Orexigen Therapeutics Inc. (OREX)  : The drugmaker, which
is one of three companies with rival obesity treatments
competing for approval, is renewing development of the
experiment obesity drug Contrave after reaching an agreement
with U.S. regulators to further study heart risks.  Vivus Inc. (VVUS)  (VVUS) has also been vying to introduce the
first new obesity medicine in the U.S.  PharMerica Corp. (PMC)  : The provider of pharmacy
services based said its board unanimously voted to reject a
hostile bid by Omnicare Inc. to acquire the Louisville,
Kentucky-based company for $15 a share.  Realty Income Corp. (O)  : The real estate investment
trust that acquires retail locations started a public offering
of 6 million shares. Proceeds will be used to pay debt.  To contact the reporter on this story:
Inyoung Hwang in New York at 
 ihwang7@bloomberg.net .  To contact the editor responsible for this story:
Nick Baker at   nbaker7@bloomberg.net . 